StonvexLoading…
StonvexStonvexStonvexCore line items from TGT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-02-01 | Annual 2024 2024-02-03 | Annual 2023 2023-01-28 |
|---|---|---|---|---|
Revenue | $104.78B | $106.57B | $107.41B | $109.12B |
Operating Income | $5.12B | $5.57B | $5.71B | $3.85B |
Net Income | $3.71B | $4.09B | $4.14B | $2.78B |
EPS (Diluted) | $8.13 | $8.86 | $8.94 | $5.98 |
Total Assets | $59.49B | $57.77B | $55.36B | $53.34B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $5.49B | $4.76B | $3.81B | $2.23B |
Free Cash Flow OCF − CapEx | $2.83B | $4.48B | $3.81B | $-1.51B |
Shares Outstanding | 452.84M | 455.57M | 461.68M | 460.35M |